The Obama you don't know September 19, 2012 | 10:19 pm |

New Post Public Reply Private Reply Replies (0) Message Board
Lmcat

The Obama you don't know

September 19, 2012 | 10:19 pm | Modified: September 20, 2012 at 12:06 am
852 Comments

Photo - President Barack Obama
President Barack Obama

Few if any of his predecessors took the oath of office with higher public hopes for his success than President Obama on Jan. 20, 2009.

Millions of Americans hailed his election as an end to partisanship, a renewal of the spirit of compromise and a reinvigoration of the nation's highest ideals at home and abroad.

Above all, as America's first black chief executive, Obama symbolized the healing of long-festering wounds that were the terrible national legacy of slavery, the Reconstruction Era and Jim Crow. We would be, finally, one nation.

But after nearly four years in office, Obama has become a sharply polarizing figure.

His admirers believe he deserves a special place alongside Wilson, the Roosevelts and LBJ as one of the architects of benevolent government.

His critics believe he is trying to remake America in the image of Europe's social democracies, replacing America's ethos of independence and individual enterprise with a welfare state inflamed by class divisions.


In an effort to get a clearer picture of Obama -- his shaping influences, his core beliefs, his political ambitions and his accomplishments -- The Washington Examiner conducted a four-month inquiry, interviewing dozens of his supporters and detractors in Chicago and elsewhere, and studying countless court transcripts, government reports and other official documents.

Over the years and in two autobiographies, Obama has presented himself to the world as many things, including radical community organizer, idealistic civil rights lawyer, dynamic reformer in the Illinois and U.S. senates, and, finally, the cool presidential voice of postpartisan hope and change.

With his air of reasonableness and moderation, he has projected a remarkably likable persona. Even in the midst of a historically dirty campaign for re-election, his likability numbers remain impressive, as seen in a recent AP-GFK Poll that found 53 percent of adults have a favorable view of him.

But beyond the spin and the polls, a starkly different picture emerges. It is a portrait of a man quite unlike his image, not a visionary reformer but rather a classic Chicago machine pol who thrives on rewarding himself and his friends with the spoils of public office, and who uses his position to punish his enemies.
Peter Schweizer captures this other Obama with a bracing statistic in his book "Throw Them All Out," published last year. In the Obama economic stimulus program's Department of Energy loans, companies owned and run by Obama contributors and friends, like Solyndra's George Kaiser, received $16.4 billion. Those not linked to the president got only $4.1 billion. The Energy Department is far from the only federal program in which favoritism has heavily influenced federal grants.

To paraphrase Tammany Hall's George Washington Plunkitt, Obama has seen his opportunities and taken them, over and over.

http://washingtonexaminer.com/introduction-th...FyZnY1lQqw

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Odessa Water Overbilling Lawsuit Surges Ahead

Updated Category News Views 181

Full Steam Ahead for Odessa's Water Fight Odessa, a dust-blown Texas town, ain't giving up without a fight. The court just lit a fire under the efforts of 46,000 residents and businesses hollering about their water bills that seemed to skyrocket outta nowhere. This court ruling lets the class action against the City of Odessa and Performance Services—they're the folks...

Continue Reading
AI Deception Challenges the Confidence of Fraud Defenses

Updated Category News Views 120

Fraud Week Spotlights AI Deception Alright, here's the rub: we're in Fraud Week 2026, and boy, is AI shaking the foundations of yesterday's fraud defenses! With all this AI talk, you would expect systems to be near invincible by now. But reality? A different beast altogether. AI has this knack of tripling up the complexity while pretending to solve it, making traditional...

Continue Reading
Choosing the Right Pressure-Treated Lumber for Projects

Updated Category News Views 115

Diving into the World of Pressure-Treated Lumber John Michael Nixa, the go-to expert from West Side Lumber, has dropped some real nuggets in the world of pressure-treated lumber. This isn't some clickbait headline; it's about making sure your deck or fence doesn't fall apart after the first thunderstorm. Understanding the Lumber Treatment Now, before you run off to the...

Continue Reading
Noël Jolié's Cream Earns Spot on Oprah's List

Updated Category News Views 98

The Powerhouse of Oprah's Seal of Approval Ever notice what happens when Oprah drops a nod towards any brand? It's like Midas touching everything gold. That's exactly the scenario with Noël Jolié, a Chicago-based luxury body care operation, hitting the jackpot by landing its Velours Silken Body Cream on Oprah's Favorite Things 2026. You can't buy this kind of press,...

Continue Reading
D-Wave's 9.5% Drop: Fraud Lawsuit Raises Investor Ire

Updated Category News Views 59

Shockwaves from D-Wave's Earnings Call August wasn't exactly a banner month for D-Wave Quantum, Inc. as their stock went down like a lead balloon following a lackluster earnings report. If you've ever had any skin in the game, you'd know a 9.5% drop isn't just peanuts—it's the equivalent of watching your prized racehorse stumble at the first hurdle. The financials spoke...

Continue Reading
Bybit Expands ByPick Game with Broader Market Reach

Updated Category News Views 124

Bybit Plays the Game of Expansion Step right up to Bybit’s latest offering – ByPick Season 2. Some folks might be scratching their heads about what's shifting in this free-to-play space, but here we are, watching a beast that’s a mix between a carnival game and a hedge fund playpen. No money exchanged, just knowledge on the line. That's right, we're diving into a...

Continue Reading
NVIDIA Faces Legal Turbulence: CEO's Exit Sparks Chaos

Updated Category News Views 98

Jensen Huang's Sudden Exit: A Barrage of Headlines In what feels like a blow delivered by a sledgehammer, NVIDIA is rocked by the abrupt resignation of its iconic co-founder and CEO, Jensen Huang. This isn't some quiet departure into the night. Nope, it's more like a cannonball being fired into the investor lounge, leaving a wreckage for all to navigate through. Huang's...

Continue Reading
Balancing Rigor and Interests in Education: Insights

Updated Category News Views 135

Education: A Balancing Act of Academics and Interests So here's the deal, folks. Education isn't just about hitting the textbooks and acing exams. It's a wild dance—balancing rigorous academics and the extracurricular hustle. Brent Reckman, the brains behind The Academy of Charter Schools in Westminster, Colorado, knows this orchestra well. In a feature with...

Continue Reading
Optikos Secures CMMC Level 2, Eyeing Defense Market

Updated Category News Views 92

Optikos Levels Up with CMMC Certification In a world where cybersecurity threats are lurking around every corner, Optikos has just joined the rarefied ranks of the top 1% of U.S. defense suppliers by grabbing the CMMC Level 2 certification. Let me tell you, this isn't just some shiny badge for show; it's a gateway to big defense contracts. Crunching the Numbers Of the...

Continue Reading
HNTB Partners with Kansas City Chiefs for New Stadium

Updated Category News Views 94

A New Chapter for the Kansas City Chiefs Are we witnessing the dawn of a new era for the Kansas City Chiefs? Officially naming HNTB as the architect for their upcoming stadium signals a strategic pivot, aimed at not just snagging eyeballs, but embedding Kansas City deeper into the sports architecture hall of fame. Unveiled during the Power Brokers Sports-Anchored...

Continue Reading

Top 5 Most Recently Viewed Articles

IMF Delegates Argentina Negotiations Amid Rising Tensions

Updated Category News Views 196

Understanding the Recent Developments in IMF Talks with Argentina The International Monetary Fund (IMF) is currently navigating a complicated landscape in its negotiations with Argentina, showcasing the ever-evolving nature of international finance and politics. Recently, Rodrigo Valdes, the IMF director for the Western Hemisphere, has officially assigned all negotiation...

Continue Reading
IO Biotech Showcases Innovative Cancer Treatments Through Vaccines

Updated Category News Views 194

IO Biotech Unveils Breakthrough Pre-Clinical Data for Cancer Vaccines IO Biotech, a clinical-stage biopharmaceutical company listed on the Nasdaq under the ticker IOBT, is at the forefront of developing immune-modulatory, off-the-shelf therapeutic cancer vaccines. Recently, the company revealed exciting data highlighting its two promising candidates: IO112 and IO170, both...

Continue Reading
Market Performance of Marijuana Stocks This October

Updated Category News Views 69

October Marijuana Stock Performance Overview The marijuana stock market has shown a diverse range of movements this October. Investors and enthusiasts remain eager to analyze these trends as companies navigate the ever-changing landscape of the cannabis industry. This article provides insights into the key movers within this sector, identifying both the top performers and...

Continue Reading
EQS Group Unveils 'Q': AI-Driven Compliance Revolution

Updated Category News Views 216

Compliance in the Fast Lane The compliance world just got a hefty upgrade with EQS Group's latest rollout: 'Q by EQS,' an AI-powered intelligence layer that's here to shake up the way compliance tasks are handled. It's integrated right into the heart of the EQS Compliance Cockpit, giving teams an edge by automating those pesky, time-sucking routines and guiding them...

Continue Reading
Olema Oncology Showcases Innovations at J.P. Morgan Healthcare Expo

Updated Category News Views 306

Olema Oncology to Present at Major Healthcare Event Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a dynamic clinical-stage biopharmaceutical company focused on developing targeted therapies for breast cancer and related conditions, is all set to present its innovative findings at the renowned J.P. Morgan Healthcare Conference. This key...

Continue Reading